October 24, 2022
Read about NervGen and its research in Alzheimer’s in this article in Health Europa
July 29, 2022
Read about NervGen and our preclinical results in stroke in this article in BioSpace
July 28, 2022
New Scientist’s Carissa Wong writes about NervGen’s potential in stroke following Cell Reports publication
July 18, 2022
Article in Contract Pharma by NervGen President & CEO, Paul Brennan, on the role of Biotech in improving Stroke outcomes.
April 16, 2021
BioProcess International features a byline from Paul Brennan.